Cary D Austin

8PUBLICATIONS
104CO-AUTHORS
Molecular targetsNutrigenomics and personalised nutritionInfectious agentsFluid-structure interaction and aeroacousticsMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jan 07, 2026
Combined antagonism of Oncostatin M (OSM) and Interleukin 6 (IL-6) provides both anti-fibrotic and anti-inflammatory benefit in pulmonary fibrosis.

Rojo A Ratsimandresy, Emma Doran, Hart S Dengler

|Dec 14, 2022
Dual antibody inhibition of KLK5 and KLK7 for Netherton syndrome and atopic dermatitis.

Joseph Chavarria-Smith, Cecilia P C Chiu, Janet K Jackman

|Sep 13, 2022
Deletion of a previously uncharacterized lipoprotein lirL confers resistance to an inhibitor of type II signal peptidase in <i>Acinetobacter baumannii</i>.

Ke-Jung Huang, Homer Pantua, Jingyu Diao

|Apr 20, 2022
Steroid-induced fibroblast growth factors drive an epithelial-mesenchymal inflammatory axis in severe asthma.

Riccardo Guidi, Daqi Xu, David F Choy

|Jan 12, 2022
Oncostatin M expression induced by bacterial triggers drives airway inflammatory and mucus secretion in severe asthma.

Sarah E Headland, Hart S Dengler, Daqi Xu

|Sep 10, 2020
A randomized, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER).

Cary D Austin, Melissa Gonzalez Edick, Ronald E Ferrando

Pageof 2

Frequent Collaborators

3 joint publications

Joseph R Arron

3 joint publications

Reynold A Panettieri

3 joint publications

Cynthia Koziol-White

3 joint publications

Riccardo Guidi